Globe Newswire NovaQuest Capital Enters Into Financing Agreement With Nevakar Inc.
6.18.19
Business Wire Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine Announce Partnership to Develop and Commercialize VT-1161 for Recurrent Vulvovaginal Candidiasis and Other Fungal Conditions
6.17.19
Azurity Pharmaceuticals Azurity Pharmaceuticals (Formerly CutisPharma) Acquires Silvergtate Pharmaceuticals
6.11.19
AP NovaQuest Capital Enters Into Financing Agreement With Brickell Biotech
6.3.19
WRAL Tech Wire Mycovia Pharmaceuticals’ Drug-1161 Shows Promise Against Drug-Resistant Infections
4.12.19
AP Mycovia Pharmaceuticals’ Drug-1598 Shows Promise Against Deadly Fungus
4.11.19
Business Wire NovaQuest Capital Enters Into Financing Agreement With Arvelle Therapeutics
2.14.19
Bloomberg NovaQuest Capital Acquires Equity Stake In Roivant Sciences
11.13.18
PR Newswire NovaQuest Capital Acquires Catalyst Clinical Research
10.31.18
Endpoints News NovaQuest Capital Enters Into Financing Agreement With Dermavant Sciences
8.28.18